An impedance-based cytotoxicity assay for real-time and label-free assessment of T-cell-mediated killing of adherent cells

Journal of Immunological Methods

Volumn 405, Issue , 2014, Pages 192-198

  Peper, Janet Kerstin ^a   Schuster, Heiko ^a   Löffler, Markus W ^a,b   Schmid Horch, Barbara ^b   Rammensee, Hans Georg ^a   Stevanović, Stefan ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Chromium release assay; Impedance; Real time; T cell cytotoxicity assay; XCELLigence

Indexed keywords

PEPTIDE;

ADHERENT CELL; AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; CELL ADHESION; CELL MEDIATED CYTOTOXICITY; CHROMIUM RELEASE ASSAY; COCULTURE; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY ASSAY; HUMAN; HUMAN CELL; IMPEDANCE; IN VITRO STUDY; INCUBATION TIME; PRIORITY JOURNAL; REAL TIME CYTOTOXICITY ASSAY; REPRODUCIBILITY; SENSITIVITY ANALYSIS; TARGET CELL;

CHROMIUM RELEASE ASSAY; IMPEDANCE; REAL TIME; T-CELL CYTOTOXICITY ASSAY; XCELLIGENCE;

AMINO ACID SEQUENCE; APOPTOSIS; CELL ADHESION; CELL LINE, TUMOR; CELL SURVIVAL; CELLS, CULTURED; CHROMIUM RADIOISOTOPES; COCULTURE TECHNIQUES; CYTOTOXICITY TESTS, IMMUNOLOGIC; CYTOTOXICITY, IMMUNOLOGIC; ELECTRIC IMPEDANCE; HLA-A2 ANTIGEN; HUMANS; INFLUENZA A VIRUS; KILLER CELLS, NATURAL; LEUKOCYTES, MONONUCLEAR; PEPTIDE FRAGMENTS; REPRODUCIBILITY OF RESULTS; T-LYMPHOCYTES; TIME FACTORS; VIRAL MATRIX PROTEINS;

EID: 84897428573     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2014.01.012     Document Type: Article

References (13)

1. Aktas E., Kucuksezer U.C., Bilgic S., Erten G., Deniz G. Relationship between CD107a expression and cytotoxic activity. Cell. Immunol. 2009, 254:149.
2. Andersen M.H., Schrama D., Thor Straten P., Becker J.C. Cytotoxic T cells. J. Invest. Dermatol. 2006, 126:32.
3. Blomberg K., Granberg C., Hemmila I., Lovgren T. Europium-labelled target cells in an assay of natural killer cell activity. I. A novel non-radioactive method based on time-resolved fluorescence. J. Immunol. Methods 1986, 86:225.
4. Brunner K.T., Mauel J., Cerottini J.C., Chapuis B. Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs. Immunology 1968, 14:181.
5. Erskine C.L., Henle A.M., Knutson K.L. Determining optimal cytotoxic activity of human Her2neu specific CD8 T cells by comparing the Cr51 release assay to the xCELLigence system. J. Vis. Exp. 2012, e3683.
6. Garboczi D.N., Hung D.T., Wiley D.C. HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:3429.
7. Glamann J., Hansen A.J. Dynamic detection of natural killer cell-mediated cytotoxicity and cell adhesion by electrical impedance measurements. Assay. Drug Dev. Technol. 2006, 4:555.
8. Hussain R.F., Nouri A.M., Oliver R.T. A new approach for measurement of cytotoxicity using colorimetric assay. J. Immunol. Methods 1993, 160:89.
9. Icheva V., Kayser S., Wolff D., Tuve S., Kyzirakos C., Bethge W., Greil J., Albert M.H., Schwinger W., Nathrath M., Schumm M., Stevanovic S., Handgretinger R., Lang P., Feuchtinger T. Adoptive transfer of Epstein-Barr virus (EBV) nuclear antigen 1-specific t cells as treatment for EBV reactivation and lymphoproliferative disorders after allogeneic stem-cell transplantation. J. Clin. Oncol. 2013, 31:39.
10. Jedema I., van der Werff N.M., Barge R.M., Willemze R., Falkenburg J.H. New CFSE-based assay to determine susceptibility to lysis by cytotoxic T cells of leukemic precursor cells within a heterogeneous target cell population. Blood 2004, 103:2677.
11. Suhrbier A., Fernan A., Burrows S.R., Saul A., Moss D.J. BLT esterase activity as an alternative to chromium release in cytotoxic T cell assays. J. Immunol. Methods 1991, 145:43.
12. Walter S., Weinschenk T., Stenzl A., Zdrojowy R., Pluzanska A., Szczylik C., Staehler M., Brugger W., Dietrich P.Y., Mendrzyk R., Hilf N., Schoor O., Fritsche J., Mahr A., Maurer D., Vass V., Trautwein C., Lewandrowski P., Flohr C., Pohla H., Stanczak J.J., Bronte V., Mandruzzato S., Biedermann T., Pawelec G., Derhovanessian E., Yamagishi H., Miki T., Hongo F., Takaha N., Hirakawa K., Tanaka H., Stevanovic S., Frisch J., Mayer-Mokler A., Kirner A., Rammensee H.G., Reinhardt C., Singh-Jasuja H. Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival. Nat. Med. 2012, 18:1254.
13. Weren A., Bonnekoh B., Schraven B., Gollnick H., Ambach A. A novel flow cytometric assay focusing on perforin release mechanisms of cytotoxic T lymphocytes. J. Immunol. Methods 2004, 289:17.